Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women

  • Technology appraisal guidance
  • TA160
  • Published: 
  • Last updated: 

Osteoporosis - primary and secondary prevention: register to attend the appeal

The Institute has received 1 appeal against the Final Appraisal Determination and Guidance on this technology. The Institute has arranged the hearing for the appeal(s) received against the FAD for the above technology. The appeal panel will convene on 15 September 2008 to hear oral representations from the appellants.

To register

The registration period for this appeal has now passed.

This page was last updated: 04 June 2009